0000950170-24-107554.txt : 20240917
0000950170-24-107554.hdr.sgml : 20240917
20240917202449
ACCESSION NUMBER: 0000950170-24-107554
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240916
FILED AS OF DATE: 20240917
DATE AS OF CHANGE: 20240917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Behbahani Ali
CENTRAL INDEX KEY: 0001613867
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42272
FILM NUMBER: 241305935
MAIL ADDRESS:
STREET 1: 2855 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MBX Biosciences, Inc.
CENTRAL INDEX KEY: 0001776111
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: 3179893100
MAIL ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
4
1
ownership.xml
4
X0508
4
2024-09-16
0001776111
MBX Biosciences, Inc.
MBX
0001613867
Behbahani Ali
2855 SAND HILL ROAD
MENLO PARK
CA
94025
false
false
true
false
false
Common Stock
2024-09-16
4
C
false
1023103
A
1023103
I
See Note 2
Common Stock
2024-09-16
4
C
false
2091383
A
3114486
I
See Note 2
Common Stock
2024-09-16
4
P
false
500000
16.00
A
3614486
I
See Note 2
Series A Convertible Preferred Stock
2024-09-16
4
C
false
12299854
D
Common Stock
1023103
0
I
See Note 2
Series B Convertible Preferred Stock
2024-09-16
4
C
false
25142840
D
Common Stock
2091383
0
I
See Note 2
Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") was convertible into Common Stock on a one-for-12.0221 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on September 16, 2024. The Preferred Stock had no expiration date.
The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
/s/ Zachary Bambach, attorney-in-fact
2024-09-17